Gilead Sciences reported $63.08B in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Acorda Therapeutics ACOR:US $ 424.14M 31.33M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
ALKERMES ALKS:US $ 1977.84M 46.64M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amgen AMGN:US $ 59196M 1969M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Coherus Biosciences CHRS:US $ 593.39M 85.95M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Gilead Sciences GILD:US $ 63080M 4872M
GlaxoSmithKline GSK:LN 89689M 10586M
Glaxosmithkline GSK:US $ 89689M 10586M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
Johnson & Johnson JNJ:US $ 178355M 3663M
Merk MRK:US $ 106668M 974M
Moderna Inc MRNA:US 27.61B 2.94B
Novartis NOVN:VX SF 125218M 6577M
Ptc Therapeutics PTCT:US $ 1799.59M 138.46M
Puma Biotechnology PBYI:US $ 200.68M 25.9M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Teva Pharmaceutical Industries TEVA:US $ 47059M 607M
United Therapeutics UTHR:US $ 5359.8M 190.7M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
YTE INCY:US $ 5054.22M 120.87M